HIGH
CVE-2026-45353
CWE-94Published: May 28, 2026· Updated: Jun 3, 2026
7.8
CVSS v3.1
EPSS:0.02%probability of exploitation in 30 daysPercentile:6.0th
Official Description
electerm is an open-sourced terminal/ssh/sftp/telnet/serialport/RDP/VNC/Spice/ftp client. From 3.0.6 to 3.8.8, This vulnerability is fixed in 3.9.0.
Technical Analysis
CVE-2026-45353 requires local access, meaning attackers must already have a foothold on the target system.
Exploitation requires low privileges, which limits the exposure to scenarios where an attacker has already gained initial access.
A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), availability disruption (denial of service), with a CVSS base score of 7.8.
CVSS v3.1 Vector Breakdown
Exploitability
Attack VectorLocal
Attack ComplexityLow
Privileges Req.Low
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityHigh
IntegrityHigh
AvailabilityHigh
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Affected Vendors & Products
electerm_project1 product(s)
electerm
Source: NVD CPE · 1 total CPE entries
Exploit & PoC Resources
NO KNOWN EXPLOITNo public exploit confirmed at this time
Exploit-DB
Offensive Security exploit database
GitHub PoC Search
Community PoC repositories
Rapid7 / Metasploit
Metasploit module search
PacketStorm
Security advisories & exploits
NVD Detail
Official NIST entry
MITRE CVE
CVE Program entry
External links open in a new tab. Always verify in a controlled environment before use.
Official Patches & Advisories
All References (2)
Quick Facts
CVE IDCVE-2026-45353
CVSS Score7.8 / 10
SeverityHIGH
WeaknessCWE-94
CISA KEVNo
EPSS (30d)0.02%
Affected1 vendor(s)
PublishedMay 28, 2026
Related CVEs (CWE-94)
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2026-45353 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.